Jiao Chen, Guanghui Li, Fen Wan, Peng Liu, Fangling Du, Yanting Shao, Qi Zhang, Zhibin Cheng, Yang Liu
Acinetobacter baumannii is a highly antibiotic-resistant pathogen causing nosocomial severe life-threatening infections, especially in critically ill patients. Capsular polysaccharide is a major virulence factor of A. baumannii both in vitro and in vivo. In this study, 220 isolates were collected in the hospital. The prevalent capsular types of A. baumannii were determined using polymerase chain reaction, and the clinical characteristics of infections were analyzed. The virulence of these strains was determined by serum-killing resistance, biofilm formation, and Galleria mellonella survival assays. Twenty-eight isolates (12.7%) carried KL2, and 22 isolates (10%) carried the types KL10, KL14, KL22, and KL52. Compared with non-KL2 (KL10, KL14, KL22, and KL52) isolates, KL2 isolates had significantly higher resistance to all antimicrobials except tigecycline, cefoperazone-sulbactam, or colistin. Seventy-five percent of KL2 A. baumannii and 72.7% of non-KL2 were highly virulent using a G. mellonella model. Biofilm formation was significantly different between the KL2 and non-KL2 groups. The biofilm production of non-KL2 A. baumannii was significantly stronger than that of KL2 A. baumannii. These findings highlight the role of KL2 as a powerful factor for drug resistance and virulence of A. baumannii.
{"title":"Virulence Characteristics and Drug Resistance of the Prevalent Capsule Types in <i>Acinetobacter baumannii</i>.","authors":"Jiao Chen, Guanghui Li, Fen Wan, Peng Liu, Fangling Du, Yanting Shao, Qi Zhang, Zhibin Cheng, Yang Liu","doi":"10.1089/mdr.2022.0310","DOIUrl":"https://doi.org/10.1089/mdr.2022.0310","url":null,"abstract":"<p><p><i>Acinetobacter baumannii</i> is a highly antibiotic-resistant pathogen causing nosocomial severe life-threatening infections, especially in critically ill patients. Capsular polysaccharide is a major virulence factor of <i>A. baumannii</i> both <i>in vitro</i> and <i>in vivo</i>. In this study, 220 isolates were collected in the hospital. The prevalent capsular types of <i>A. baumannii</i> were determined using polymerase chain reaction, and the clinical characteristics of infections were analyzed. The virulence of these strains was determined by serum-killing resistance, biofilm formation, and <i>Galleria mellonella</i> survival assays. Twenty-eight isolates (12.7%) carried KL2, and 22 isolates (10%) carried the types KL10, KL14, KL22, and KL52. Compared with non-KL2 (KL10, KL14, KL22, and KL52) isolates, KL2 isolates had significantly higher resistance to all antimicrobials except tigecycline, cefoperazone-sulbactam, or colistin. Seventy-five percent of KL2 <i>A. baumannii</i> and 72.7% of non-KL2 were highly virulent using a <i>G. mellonella</i> model. Biofilm formation was significantly different between the KL2 and non-KL2 groups. The biofilm production of non-KL2 <i>A. baumannii</i> was significantly stronger than that of KL2 <i>A. baumannii.</i> These findings highlight the role of KL2 as a powerful factor for drug resistance and virulence of <i>A. baumannii.</i></p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":"29 7","pages":"274-279"},"PeriodicalIF":2.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9788131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Luciana Sartori, Fábio P Sellera, Bruna Fuga, Elder Sano, Daniel F M Monte, Brenda Cardoso, Lucas de Angelis Côrtes, Nilton Lincopan
The global dissemination of extended-spectrum-β-lactamase (ESBL)-producing Escherichia coli has been considered a critical issue within a One Health framework. The aim of this study was to perform a genomic investigation of an ESBL-producing E. coli strain belonging to the globally spread sequence type/clonal complex ST90/CC23, isolated from gastrointestinal tract of a dog, in Brazil. Besides CTX-M-15 ESBL, this E. coli isolate carried mutations conferring resistance to human and veterinary fluoroquinolones (GyrA [Ser83Leu, Asp87Asn], ParC [Ser80Ile] and ParE [Ser458Ala]), and resistance determinants to disinfectants and pesticides. Noteworthy, phylogenomic analysis revealed that this multidrug E. coli strain clustered with ST90 lineages isolated from human, dog, and livestock in Brazil. The phylogenetic tree also revealed that this E. coli strain shares a common ancestor with isolates from the United States, Russia, Germany, and China, highlighting the potential global spreading of this clone. In summary, we report genomic data of CTX-M-15-positive E.coli ST90 colonizing a pet. Colonization of companion animals by critical resistant pathogens highlights the need for close monitoring to better understand the epidemiology and genetic factors contributing for successful adaptation of global clones at the human-animal interface.
产生广谱β-内酰胺酶(ESBL)的大肠杆菌的全球传播被认为是“同一个健康”框架内的一个关键问题。本研究的目的是对一株产esbl的大肠杆菌菌株进行基因组研究,该菌株属于全球传播的序列型/克隆复合物ST90/CC23,该菌株从巴西的一只狗的胃肠道中分离出来。除了CTX-M-15 ESBL外,该大肠杆菌分离物还携带对人用和兽用氟喹诺酮类药物(GyrA [Ser83Leu, Asp87Asn], ParC [Ser80Ile]和ParE [Ser458Ala])耐药的突变,以及对消毒剂和农药的耐药决定因素。值得注意的是,系统基因组学分析显示,该多药大肠杆菌菌株与从巴西人、狗和牲畜中分离的ST90谱系聚集在一起。系统发育树还显示,该大肠杆菌菌株与来自美国、俄罗斯、德国和中国的分离株具有共同的祖先,突出了该克隆可能在全球传播。总之,我们报告了ctx - m -15阳性大肠杆菌ST90定殖宠物的基因组数据。关键耐药病原体对伴侣动物的定植突出了密切监测的必要性,以便更好地了解在人-动物界面成功适应全球克隆的流行病学和遗传因素。
{"title":"Phylogenomic Analysis of CTX-M-15-Positive <i>Escherichia coli</i> from Companion Animal Reveals Intercontinental Dissemination of ST90 Within a One Health Framework.","authors":"Luciana Sartori, Fábio P Sellera, Bruna Fuga, Elder Sano, Daniel F M Monte, Brenda Cardoso, Lucas de Angelis Côrtes, Nilton Lincopan","doi":"10.1089/mdr.2022.0249","DOIUrl":"https://doi.org/10.1089/mdr.2022.0249","url":null,"abstract":"<p><p>The global dissemination of extended-spectrum-β-lactamase (ESBL)-producing <i>Escherichia coli</i> has been considered a critical issue within a One Health framework. The aim of this study was to perform a genomic investigation of an ESBL-producing <i>E. coli</i> strain belonging to the globally spread sequence type/clonal complex ST90/CC23, isolated from gastrointestinal tract of a dog, in Brazil. Besides CTX-M-15 ESBL, this <i>E. coli</i> isolate carried mutations conferring resistance to human and veterinary fluoroquinolones (GyrA [Ser83Leu, Asp87Asn], ParC [Ser80Ile] and ParE [Ser458Ala]), and resistance determinants to disinfectants and pesticides. Noteworthy, phylogenomic analysis revealed that this multidrug <i>E. coli</i> strain clustered with ST90 lineages isolated from human, dog, and livestock in Brazil. The phylogenetic tree also revealed that this <i>E. coli</i> strain shares a common ancestor with isolates from the United States, Russia, Germany, and China, highlighting the potential global spreading of this clone. In summary, we report genomic data of CTX-M-15-positive <i>E.coli</i> ST90 colonizing a pet. Colonization of companion animals by critical resistant pathogens highlights the need for close monitoring to better understand the epidemiology and genetic factors contributing for successful adaptation of global clones at the human-animal interface.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":"29 7","pages":"296-301"},"PeriodicalIF":2.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9849041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Helio S Sader, Rodrigo E Mendes, Mariana Castanheira
{"title":"Re: \"Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States\" by Karlsson et al.","authors":"Helio S Sader, Rodrigo E Mendes, Mariana Castanheira","doi":"10.1089/mdr.2022.0260","DOIUrl":"https://doi.org/10.1089/mdr.2022.0260","url":null,"abstract":"","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":"29 7","pages":"316-317"},"PeriodicalIF":2.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9785436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01Epub Date: 2023-02-28DOI: 10.1089/mdr.2022.0212
Marco S Perez-Ayala, José Antonio Alvarez, Alejandro E Macias, Brenda J Torres-Murillo
This study aimed to identify variation in the minimum biocidal concentration (MBC) over time, comparing three commercial super-oxidized solutions with different chemical compositions. In the bactericidal assay, the following bacteria were tested: Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), Staphylococcus aureus (ATCC 25923), and for each ATCC, one wild-type strain was used. In vitro experiments were performed in triplicate at 0, 60, and 120 days of follow up. A commercial formulation based on sodium and chloride ions (SCSS) was tested using a standard accelerated aging protocol. Data were analyzed with the Friedman and Wilcoxon signed-rank tests. The results showed that super-oxidized solution bases of 20 ppm of sodium (SSS) had a significant change in MBC at 120 days (p < 0.001), whereas SCSS remained stable during the same period (p = 0.18). However, after accelerated aging treatment, the MBC of SCSS increased (p < 0.001). With our proposed approach, the two SSS showed MBC variation at 120 days, whereas SCSS showed stability over time, similar to chlorhexidine, but lost its bactericidal properties after accelerated aging treatment.
本研究旨在通过比较三种具有不同化学成分的商业超氧化溶液,确定最小杀生物剂浓度(MBC)随时间的变化。在杀菌试验中,测试了以下细菌:大肠杆菌(ATCC 25922)、铜绿假单胞菌(ATCC 27853)、金黄色葡萄球菌(ATCC 259 23),并且对于每个ATCC,使用一种野生型菌株。在随访0、60和120天时进行一式三份的体外实验。使用标准加速老化方案测试基于钠和氯离子(SCSS)的商业制剂。数据采用Friedman和Wilcoxon符号秩检验进行分析。结果表明,20 ppm的钠(SSS)在120天时MBC有显著变化(p p = 0.18)。而加速老化处理后,SCSS的MBC增加(p
{"title":"How Does Time Affect the Antimicrobial Activity of Super-Oxidized Commercial Antiseptic Solutions? An <i>In Vitro</i> Test.","authors":"Marco S Perez-Ayala, José Antonio Alvarez, Alejandro E Macias, Brenda J Torres-Murillo","doi":"10.1089/mdr.2022.0212","DOIUrl":"10.1089/mdr.2022.0212","url":null,"abstract":"<p><p>This study aimed to identify variation in the minimum biocidal concentration (MBC) over time, comparing three commercial super-oxidized solutions with different chemical compositions. In the bactericidal assay, the following bacteria were tested: <i>Escherichia coli</i> (ATCC 25922), <i>Pseudomonas aeruginosa</i> (ATCC 27853), <i>Staphylococcus aureus</i> (ATCC 25923), and for each ATCC, one wild-type strain was used. <i>In vitro</i> experiments were performed in triplicate at 0, 60, and 120 days of follow up. A commercial formulation based on sodium and chloride ions (SCSS) was tested using a standard accelerated aging protocol. Data were analyzed with the Friedman and Wilcoxon signed-rank tests. The results showed that super-oxidized solution bases of 20 ppm of sodium (SSS) had a significant change in MBC at 120 days (<i>p</i> < 0.001), whereas SCSS remained stable during the same period (<i>p</i> = 0.18). However, after accelerated aging treatment, the MBC of SCSS increased (<i>p</i> < 0.001). With our proposed approach, the two SSS showed MBC variation at 120 days, whereas SCSS showed stability over time, similar to chlorhexidine, but lost its bactericidal properties after accelerated aging treatment.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":"29 7","pages":"309-315"},"PeriodicalIF":2.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9788870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.1089/mdr.2023.29005.rfs2022
Sabine Schuster
{"title":"RFS Proudly Announces the 2022 Award Recipient for <i>Microbial Drug Resistance</i>.","authors":"Sabine Schuster","doi":"10.1089/mdr.2023.29005.rfs2022","DOIUrl":"https://doi.org/10.1089/mdr.2023.29005.rfs2022","url":null,"abstract":"","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":"29 7","pages":"273"},"PeriodicalIF":2.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9803996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
There is a scarcity of data regarding the antimicrobial susceptibility testing profiles of nontuberculous mycobacterial (NTM) in Israel and other Middle Eastern countries. We aimed to describe the antimicrobial susceptibility profiles of NTM in Israel. A total of 410 clinical isolates of NTM, identified to the species level using matrix-assisted laser desorption ionization-time of flight mass spectrometry or hsp65 gene sequencing, were included. Minimum inhibitory concentrations for slowly growing mycobacteria (SGM) and rapidly growing mycobacteria (RGM) for 12 and 11 drugs were determined using the Sensititre SLOMYCOI and RAPMYCOI broth microdilution plates, respectively. Mycobacterium avium complex (MAC) was the most frequently isolated species (n = 148; 36%), followed by Mycobacterium simiae (n = 93; 23%), Mycobacterium abscessus group (n = 62; 15%), Mycobacterium kansasii (n = 27; 7%), and Mycobacterium fortuitum (n = 22; 5%) accounting together for 86% of isolates. The most active agents against SGM were amikacin (98%/85%/100%) and clarithromycin (97%/99%/100%), followed by moxifloxacin (25%/10%/100%) and linezolid (3%/6%/100%) for MAC, M. simiae, and M. kansasii, respectively. For RGM, the most active agents were amikacin (98%/100%/88%) followed by linezolid (48%/80%/100%) and clarithromycin (39%/28%/94%) for M. abscessus group, M. fortuitum, and M. chelonae, respectively. These findings can assist in guiding the treatment of NTM infections.
{"title":"Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.","authors":"Yizhak Hershko, Amos Adler","doi":"10.1089/mdr.2023.0024","DOIUrl":"https://doi.org/10.1089/mdr.2023.0024","url":null,"abstract":"<p><p>There is a scarcity of data regarding the antimicrobial susceptibility testing profiles of nontuberculous mycobacterial (NTM) in Israel and other Middle Eastern countries. We aimed to describe the antimicrobial susceptibility profiles of NTM in Israel. A total of 410 clinical isolates of NTM, identified to the species level using matrix-assisted laser desorption ionization-time of flight mass spectrometry or <i>hsp65</i> gene sequencing, were included. Minimum inhibitory concentrations for slowly growing mycobacteria (SGM) and rapidly growing mycobacteria (RGM) for 12 and 11 drugs were determined using the Sensititre SLOMYCOI and RAPMYCOI broth microdilution plates, respectively. <i>Mycobacterium avium</i> complex (MAC) was the most frequently isolated species (<i>n</i> = 148; 36%), followed by <i>Mycobacterium simiae</i> (<i>n</i> = 93; 23%), <i>Mycobacterium abscessus</i> group (<i>n</i> = 62; 15%), <i>Mycobacterium kansasii</i> (<i>n</i> = 27; 7%), and <i>Mycobacterium fortuitum</i> (<i>n</i> = 22; 5%) accounting together for 86% of isolates. The most active agents against SGM were amikacin (98%/85%/100%) and clarithromycin (97%/99%/100%), followed by moxifloxacin (25%/10%/100%) and linezolid (3%/6%/100%) for MAC, <i>M. simiae</i>, and <i>M. kansasii</i>, respectively. For RGM, the most active agents were amikacin (98%/100%/88%) followed by linezolid (48%/80%/100%) and clarithromycin (39%/28%/94%) for <i>M. abscessus</i> group, <i>M. fortuitum</i>, and <i>M. chelonae</i>, respectively. These findings can assist in guiding the treatment of NTM infections.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":"29 7","pages":"302-308"},"PeriodicalIF":2.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9791202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dalila Benremila, Ferhat Djoudi, Alima Gharout-Sait, Slimane Kheloufi, Andrea Spitaleri, Simone Battaglia, Andrea Maurizio Cabibbe, Daniela Maria Cirillo
In this study, we aimed to characterize drug-resistant strains by whole-genome sequencing (WGS), to describe the spreading lineages and the history of transmission. Drug susceptibility testing was performed by 96-well broth microdilution plates. The genomic DNA was extracted and purified; libraries were prepared and run on the Illumina NextSeq500 System. Among 82 isolates, 21 tuberculosis (TB) isolates (25.6%) were drug resistant, including 10 MDR and 4 pre-extensively drug-resistant (XDR)-TB. The mutation Ser315Thr in the katG gene was confirmed in 15 isolates. In rpoB, Ser450Leu and His445Asp mutations were the most common. Asp94Asn and Ala90Val mutations were reported in gyrA. The LAM family, the most TB drug resistant, was widely predominant in the north and the T sublineage in the south of the country. This study provides the first insight on TB drug resistance using WGS in Algeria and clearly describes the first pre-XDR-TB cases and lineage distribution across the country.
{"title":"Comprehensive Drug Resistance Characterization of Pulmonary Tuberculosis in Algeria: Insights on <i>Mycobacterium tuberculosis</i> Strains by Whole-Genome Sequencing.","authors":"Dalila Benremila, Ferhat Djoudi, Alima Gharout-Sait, Slimane Kheloufi, Andrea Spitaleri, Simone Battaglia, Andrea Maurizio Cabibbe, Daniela Maria Cirillo","doi":"10.1089/mdr.2022.0321","DOIUrl":"https://doi.org/10.1089/mdr.2022.0321","url":null,"abstract":"<p><p>In this study, we aimed to characterize drug-resistant strains by whole-genome sequencing (WGS), to describe the spreading lineages and the history of transmission. Drug susceptibility testing was performed by 96-well broth microdilution plates. The genomic DNA was extracted and purified; libraries were prepared and run on the Illumina NextSeq500 System. Among 82 isolates, 21 tuberculosis (TB) isolates (25.6%) were drug resistant, including 10 MDR and 4 pre-extensively drug-resistant (XDR)-TB. The mutation Ser315Thr in the <i>kat</i>G gene was confirmed in 15 isolates. In <i>rpo</i>B, Ser450Leu and His445Asp mutations were the most common. Asp94Asn and Ala90Val mutations were reported in <i>gyr</i>A. The LAM family, the most TB drug resistant, was widely predominant in the north and the T sublineage in the south of the country. This study provides the first insight on TB drug resistance using WGS in Algeria and clearly describes the first pre-XDR-TB cases and lineage distribution across the country.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":"29 7","pages":"280-295"},"PeriodicalIF":2.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9791890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ulises Garza-Ramos, Jesús Silva-Sánchez, Luis Esaú López-Jácome, Melissa Hernández-Durán, Claudia Adriana Colín-Castro, Alejandro Sánchez-Pérez, Jonathan Rodríguez-Santiago, Rayo Morfín-Otero, Eduardo Rodriguez-Noriega, María-Del-Consuelo Velázquez-Acosta, María Del Rosario Vázquez-Larios, José Manuel Feliciano-Guzmán, Fabián Rojas-Larios, Alfredo Ponce-De-Leon, Margarita Lozano-Garcia, Elena Victoria Choy-Chang, Eduardo López-Gutiérrez, Aarón Molina-Jaimes, Mariana Gil-Veloz, Reyna Edith Corte-Rojas, Ismelda López-Ovilla, Jose Luis Ramirez-Mis, Dora Elia Rodríguez-Balderas, Alejandro Molina-Chavarria, Cecilia Padilla-Ibarra, Maria Angelina Quevedo-Ramos, Christian Daniel Mireles-Dávalos, Nadia Rodríguez-Medina, Daira Rubio-Mendoza, Carlos Córdova-Fletes, Flora Cruz-López, Dilva Angelina Becerra-Montejano, Roberto Mercado-Longoria, Rebeca Thelma Martínez-Villarreal, Nicolás Rogelio Eric Barlandas-Rendón, Juan Pablo Mena-Ramírez, Carlos Antonio Couoh-May, Margarita Alcaraz-Espejel, César Adame-Alvarez, Lourdes Hernández-Vicente, Elvira Garza-González
In this study, we report the carbapenemase-encoding genes and colistin resistance in Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa in the second year of the COVID-19 pandemic. Clinical isolates included carbapenem-resistant K. pneumoniae, carbapenem-resistant E. coli, carbapenem-resistant A. baumannii, and carbapenem-resistant P. aeruginosa. Carbapenemase-encoding genes were detected by PCR. Carbapenem-resistant K. pneumoniae and carbapenem-resistant E. coli isolates were analyzed using the Rapid Polymyxin NP assay. mcr genes were screened by PCR. Pulsed-field gel electrophoresis and whole-genome sequencing were performed on representative isolates. A total of 80 carbapenem-resistant E. coli, 103 carbapenem-resistant K. pneumoniae, 284 carbapenem-resistant A. baumannii, and 129 carbapenem-resistant P. aeruginosa isolates were recovered. All carbapenem-resistant E. coli and carbapenem-resistant K. pneumoniae isolates were included for further analysis. A selection of carbapenem-resistant A. baumannii and carbapenem-resistant P. aeruginosa strains was further analyzed (86 carbapenem-resistant A. baumannii and 82 carbapenem-resistant P. aeruginosa). Among carbapenem-resistant K. pneumoniae and carbapenem-resistant E. coli isolates, the most frequent gene was blaNDM (86/103 [83.5%] and 72/80 [90%], respectively). For carbapenem-resistant A. baumannii, the most frequently detected gene was blaOXA-40 (52/86, 60.5%), and for carbapenem-resistant P. aeruginosa, was blaVIM (19/82, 23.2%). For carbapenem-resistant A. baumannii, five indistinguishable pulsotypes were detected. Circulation of K. pneumoniae New Delhi metallo-β-lactamase (NDM) and E. coli NDM was detected in Mexico. High virulence sequence types (STs), such as K. pneumoniae ST307, E. coli ST167, P. aeruginosa ST111, and A. baumannii ST2, were detected. Among K. pneumoniae isolates, 18/101 (17.8%) were positive for the Polymyxin NP test (two, 11.0% positive for the mcr-1 gene, and one, 5.6% with disruption of the mgrB gene). All E. coli isolates were negative for the Polymyxin NP test. In conclusion, K. pneumoniae NDM and E. coli NDM were detected in Mexico, with the circulation of highly virulent STs. These results are relevant in clinical practice to guide antibiotic therapies considering the molecular mechanisms of resistance to carbapenems.
{"title":"Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network.","authors":"Ulises Garza-Ramos, Jesús Silva-Sánchez, Luis Esaú López-Jácome, Melissa Hernández-Durán, Claudia Adriana Colín-Castro, Alejandro Sánchez-Pérez, Jonathan Rodríguez-Santiago, Rayo Morfín-Otero, Eduardo Rodriguez-Noriega, María-Del-Consuelo Velázquez-Acosta, María Del Rosario Vázquez-Larios, José Manuel Feliciano-Guzmán, Fabián Rojas-Larios, Alfredo Ponce-De-Leon, Margarita Lozano-Garcia, Elena Victoria Choy-Chang, Eduardo López-Gutiérrez, Aarón Molina-Jaimes, Mariana Gil-Veloz, Reyna Edith Corte-Rojas, Ismelda López-Ovilla, Jose Luis Ramirez-Mis, Dora Elia Rodríguez-Balderas, Alejandro Molina-Chavarria, Cecilia Padilla-Ibarra, Maria Angelina Quevedo-Ramos, Christian Daniel Mireles-Dávalos, Nadia Rodríguez-Medina, Daira Rubio-Mendoza, Carlos Córdova-Fletes, Flora Cruz-López, Dilva Angelina Becerra-Montejano, Roberto Mercado-Longoria, Rebeca Thelma Martínez-Villarreal, Nicolás Rogelio Eric Barlandas-Rendón, Juan Pablo Mena-Ramírez, Carlos Antonio Couoh-May, Margarita Alcaraz-Espejel, César Adame-Alvarez, Lourdes Hernández-Vicente, Elvira Garza-González","doi":"10.1089/mdr.2022.0226","DOIUrl":"https://doi.org/10.1089/mdr.2022.0226","url":null,"abstract":"<p><p>In this study, we report the carbapenemase-encoding genes and colistin resistance in <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, <i>Acinetobacter baumannii</i>, and <i>Pseudomonas aeruginosa</i> in the second year of the COVID-19 pandemic. Clinical isolates included carbapenem-resistant <i>K. pneumoniae</i>, carbapenem-resistant <i>E. coli</i>, carbapenem-resistant <i>A. baumannii</i>, and carbapenem-resistant <i>P. aeruginosa</i>. Carbapenemase-encoding genes were detected by PCR. Carbapenem-resistant <i>K. pneumoniae</i> and carbapenem-resistant <i>E. coli</i> isolates were analyzed using the Rapid Polymyxin NP assay. <i>mcr</i> genes were screened by PCR. Pulsed-field gel electrophoresis and whole-genome sequencing were performed on representative isolates. A total of 80 carbapenem-resistant <i>E. coli</i>, 103 carbapenem-resistant <i>K. pneumoniae</i>, 284 carbapenem-resistant <i>A. baumannii</i>, and 129 carbapenem-resistant <i>P. aeruginosa</i> isolates were recovered. All carbapenem-resistant <i>E. coli</i> and carbapenem-resistant <i>K. pneumoniae</i> isolates were included for further analysis. A selection of carbapenem-resistant <i>A. baumannii</i> and carbapenem-resistant <i>P. aeruginosa</i> strains was further analyzed (86 carbapenem-resistant <i>A. baumannii</i> and 82 carbapenem-resistant <i>P. aeruginosa</i>). Among carbapenem-resistant <i>K. pneumoniae</i> and carbapenem-resistant <i>E. coli</i> isolates, the most frequent gene was <i>bla</i><sub>NDM</sub> (86/103 [83.5%] and 72/80 [90%], respectively). For carbapenem-resistant <i>A. baumannii</i>, the most frequently detected gene was <i>bla</i><sub>OXA-40</sub> (52/86, 60.5%), and for carbapenem-resistant <i>P. aeruginosa</i>, was <i>bla</i><sub>VIM</sub> (19/82, 23.2%). For carbapenem-resistant <i>A. baumannii</i>, five indistinguishable pulsotypes were detected. Circulation of <i>K. pneumoniae</i> New Delhi metallo-β-lactamase (NDM) and <i>E. coli</i> NDM was detected in Mexico. High virulence sequence types (STs), such as <i>K. pneumoniae</i> ST307, <i>E. coli</i> ST167, <i>P. aeruginosa</i> ST111, and <i>A. baumannii</i> ST2, were detected. Among <i>K. pneumoniae</i> isolates, 18/101 (17.8%) were positive for the Polymyxin NP test (two, 11.0% positive for the <i>mcr-1</i> gene, and one, 5.6% with disruption of the <i>mgrB</i> gene). All <i>E. coli</i> isolates were negative for the Polymyxin NP test. In conclusion, <i>K. pneumoniae</i> NDM and <i>E. coli</i> NDM were detected in Mexico, with the circulation of highly virulent STs. These results are relevant in clinical practice to guide antibiotic therapies considering the molecular mechanisms of resistance to carbapenems.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":"29 6","pages":"239-248"},"PeriodicalIF":2.6,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10003269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: This study aimed to determine the epidemiology of gram-negative bacteria (GNB) isolated in the newborn intensive care unit (NICU) population, to assess their antibiotic susceptibility patterns and possible associated risk factors. Methods: All neonates admitted to the NICU of Abderrezak-Bouhara hospital (Skikda, Algeria) with a clinical diagnosis of neonatal infections from March to May 2019 were included in the study. The extended-spectrum β-lactamase (ESBLs), plasmidic cephalosporinase (pAmpC), and carbapenemases genes were screened by polymerase chain reaction (PCR) and sequencing. PCR amplification of oprD among carbapenem-resistant Pseudomonas aeruginosa isolates was also performed. The clonal relatedness of the ESBLs isolates was studied using multilocus sequence typing (MLST). Results: Among 148 clinical specimens, 36 (24.3%) GNB strains were isolated from urine (n = 22), wound (n = 8), stool (n = 3), and blood (n = 3) samples. The bacterial species identified were Escherichia coli (n = 13), Klebsiella pneumoniae (n = 5), Enterobacter cloacae (n = 3), Serratia marcescens (n = 3), Salmonella spp. (n = 3), Proteus mirabilis (n = 1), P. aeruginosa (n = 5), and Acinetobacter baumannii (n = 3). PCR and sequencing showed that eleven Enterobacterales isolates harbored the blaCTX-M-15 gene, two E. coli isolates harbored the blaCMY-2 gene, and three A. baumannii isolates harbored both blaOXA-23 and blaOXA-51 genes. Also, five strains of P. aeruginosa were found to harbor mutations in the oprD gene. MLST showed that the K. pneumoniae strains belonged to ST13 and ST189, E. coli belonged to ST69, and E. cloacae belonged to ST214. Different risk factors that could predict positive GNB cultures were found, including female sex, Apgar score <8 at 5 min of life, enteral nutrition, antibiotic use, and extended length of hospitalization. Conclusion: Our study highlights the importance of determining the epidemiology of pathogens causing neonatal infections, their sequence types (ST), and their antibiotic susceptibility patterns to address rapidly a correct antibiotic treatment regimen.
{"title":"Antimicrobial Resistance Among Gram-Negative Bacteria Isolated in the Newborn Intensive Care Unit at Abderrezak-Bouhara Hospital of Skikda, Algeria.","authors":"Asma Labid, Sarah Benouagueni, Aida Mehainaoui, Djamila Gacemi Kirane, Abdelaziz Touati","doi":"10.1089/mdr.2022.0254","DOIUrl":"https://doi.org/10.1089/mdr.2022.0254","url":null,"abstract":"<p><p><b><i>Background:</i></b> This study aimed to determine the epidemiology of gram-negative bacteria (GNB) isolated in the newborn intensive care unit (NICU) population, to assess their antibiotic susceptibility patterns and possible associated risk factors. <b><i>Methods:</i></b> All neonates admitted to the NICU of Abderrezak-Bouhara hospital (Skikda, Algeria) with a clinical diagnosis of neonatal infections from March to May 2019 were included in the study. The extended-spectrum β-lactamase <b>(</b>ESBLs), plasmidic cephalosporinase (pAmpC), and carbapenemases genes were screened by polymerase chain reaction (PCR) and sequencing. PCR amplification of <i>oprD</i> among carbapenem-resistant <i>Pseudomonas aeruginosa</i> isolates was also performed. The clonal relatedness of the ESBLs isolates was studied using multilocus sequence typing <i>(</i>MLST). <b><i>Results:</i></b> Among 148 clinical specimens, 36 (24.3%) GNB strains were isolated from urine (<i>n</i> = 22), wound (<i>n</i> = 8), stool (<i>n</i> = 3), and blood (<i>n</i> = 3) samples. The bacterial species identified were <i>Escherichia coli</i> (<i>n</i> = 13), <i>Klebsiella pneumoniae</i> (<i>n</i> = 5), <i>Enterobacter cloacae</i> (<i>n</i> = 3), <i>Serratia marcescens</i> (<i>n</i> = 3), <i>Salmonella</i> spp. (<i>n</i> = 3), <i>Proteus mirabilis</i> (<i>n</i> = 1), <i>P. aeruginosa</i> (<i>n</i> = 5), and <i>Acinetobacter baumannii</i> (<i>n</i> = 3). PCR and sequencing showed that eleven <i>Enterobacterales</i> isolates harbored the <i>bla</i><sub>CTX-M-15</sub> gene, two <i>E. coli</i> isolates harbored the <i>bla</i><sub>CMY-2</sub> gene, and three <i>A. baumannii</i> isolates harbored both <i>bla</i><sub>OXA-23</sub> and <i>bla</i><sub>OXA-51</sub> genes. Also, five strains of <i>P. aeruginosa</i> were found to harbor mutations in the <i>oprD</i> gene. MLST showed that the <i>K. pneumoniae</i> strains belonged to ST13 and ST189, <i>E. coli</i> belonged to ST69, and <i>E. cloacae</i> belonged to ST214. Different risk factors that could predict positive GNB cultures were found, including female sex, Apgar score <8 at 5 min of life, enteral nutrition, antibiotic use, and extended length of hospitalization. <b><i>Conclusion:</i></b> Our study highlights the importance of determining the epidemiology of pathogens causing neonatal infections, their sequence types (ST), and their antibiotic susceptibility patterns to address rapidly a correct antibiotic treatment regimen.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":"29 6","pages":"229-238"},"PeriodicalIF":2.6,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10020722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"<i>Letter to the Editor</i>: A Porcine <i>Enterococcus hirae</i> Shares a <i>poxtA</i>-Carrying Plasmid with a Human <i>Enterococcus faecium</i> Isolate.","authors":"Marzia Cinthi, Sonia Nina Coccitto, Serena Simoni, Cristiana Garofalo, Cristiana Cesaro, Carla Vignaroli, Andrea Brenciani, Eleonora Giovanetti","doi":"10.1089/mdr.2022.0201","DOIUrl":"https://doi.org/10.1089/mdr.2022.0201","url":null,"abstract":"","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":"29 6","pages":"271-272"},"PeriodicalIF":2.6,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9647525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}